thiorphan has been researched along with perindopril in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A | 1 |
Gajda, M; Gebska, A; Guzik, TJ; Jawien, J; Korbut, R; Kus, K; Marcinkiewicz, J; Niepsuj, A; Nowak, B; Olszanecki, R; Pyka-Fosciak, G; Suski, M; Toton-Zuranska, J | 1 |
2 other study(ies) available for thiorphan and perindopril
Article | Year |
---|---|
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan | 1999 |
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
Topics: Angiotensin I; Animals; Antigens, CD; Aorta; Apolipoproteins E; Atherosclerosis; CD4-Positive T-Lymphocytes; Dendritic Cells; Female; Imidazoles; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Perindopril; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Thiorphan | 2012 |